TVM CAPITAL LIFE SCIENCE
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Over several fund generations, their investment strategy has included a multi-stage investment approach spanning discovery to market ready companies as well as profitable companies searching for growth capital. Their investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. They invest in Canada, the U.S., Germany and Western Europe with their dedicated team of investment professionals based in Montreal and Munich.
TVM CAPITAL LIFE SCIENCE
Industry:
Finance Financial Services Health Care Venture Capital
Founded:
1983-01-01
Status:
Active
Contact:
+49899989920
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box Euro IPv6
Similar Organizations
MassMutual Ventures
MMV is a multi-stage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
SFC Capital
Early-stage investor combining its own angel syndicate & seed funds to provide investors with diversified exposure to SEIS/EIS businesses.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-19 | ImmunoRx Pharma | ImmunoRx Pharma acquired by TVM Capital Life Science | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-03 | Egg Medical | TVM Capital Life Science investment in Venture Round - Egg Medical | 13 M USD |
| 2022-02-01 | Centogene | TVM Capital Life Science investment in Post-IPO Equity - Centogene | 15 M EUR |
| 2021-03-03 | Access Vascular | TVM Capital Life Science investment in Series B - Access Vascular | 20 M USD |
| 2021-02-12 | Kent Imaging | TVM Capital Life Science investment in Venture Round - Kent Imaging | 15 M USD |
| 2021-02-01 | Vespina Lifesciences | TVM Capital Life Science investment in Venture Round - Vespina Lifesciences | N/A |
| 2020-04-16 | leon nanodrugs | TVM Capital Life Science investment in Series B - leon nanodrugs | N/A |
| 2019-03-04 | Emovi | TVM Capital Life Science investment in Series C - Emovi | 15 M CAD |
| 2017-10-03 | Panthera Dental inc | TVM Capital Life Science investment in Venture Round - Panthera Dental inc | N/A |
| 2017-09-19 | Acer Therapeutics | TVM Capital Life Science investment in Post-IPO Equity - Acer Therapeutics | 15.7 M USD |
| 2017-06-13 | Centogene | TVM Capital Life Science investment in Series A - Centogene | 25 M EUR |